SLC7A11 and metabolic dysfunction-associated steatohepatitis: In a mouse NASH model, liver fibrosis was markedly more pronounced in SLC7A11 knockout mice than in their wild-type counterparts under identical conditions, whereas SLC7A11 overexpression in mouse hepatocytes ameliorated liver fibrosis.